Phibro Animal Health Corporation – NASDAQ:PAHC
Phibro Animal Health stock price today
$31.85
+10.8
+51.31%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Phibro Animal Health stock price monthly change
+20.42%
month
Phibro Animal Health stock price quarterly change
+20.42%
quarter
Phibro Animal Health stock price yearly change
+80.84%
year
Phibro Animal Health key metrics
Market Cap | 874.47M |
Enterprise value | 1.08B |
P/E | 48.98 |
EV/Sales | 1.03 |
EV/EBITDA | 10.19 |
Price/Sales | 0.81 |
Price/Book | 3.29 |
PEG ratio | -0.07 |
EPS | 0.92 |
Revenue | 1.01B |
EBITDA | 103.96M |
Income | 37.44M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 1.66% |
Oper. margin | 6.33% |
Gross margin | 31.31% |
EBIT margin | 6.33% |
EBITDA margin | 10.2% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePhibro Animal Health stock price history
Phibro Animal Health stock forecast
Phibro Animal Health financial statements
| Jun 2022 | 255.3M | 7.5M | 2.94% |
|---|---|---|---|
| Mar 2023 | 245.7M | 10.04M | 4.09% |
| Jun 2023 | 255.04M | 11.49M | 4.51% |
| Mar 2024 | 263.22M | 8.40M | 3.19% |
| 2026 | 1.05B | 35.8M | 3.41% |
|---|---|---|---|
| 2027 | 1.09B | 65.41M | 5.97% |
Analysts Price target
Financials & Ratios estimates
| 2023-05-04 | 0.34 | 0.29 |
|---|
Paying a dividend greater than earnings.
2.28%
Yield TTM
| Payout ratio | 111.7% |
|---|
| 2020 | 1.83% |
|---|---|
| 2021 | 1.66% |
| 2022 | 2.51% |
| 2023 | 3.5% |
| 2024 | 2.82% |
| Dec 2022 | 961833000 | 693.46M | 72.1% |
|---|---|---|---|
| Mar 2023 | 965432000 | 693.10M | 71.79% |
| Jun 2023 | 971397000 | 688.88M | 70.92% |
| Mar 2024 | 979035000 | 708.94M | 72.41% |
| Jun 2022 | 1.57M | -9.54M | 12.38M |
|---|---|---|---|
| Mar 2023 | 6.25M | -37.77M | 284K |
| Jun 2023 | 20.23M | -10.28M | -6.33M |
| Mar 2024 | 11.40M | 1.13M | 4.85M |
Phibro Animal Health alternative data
| Aug 2023 | 1,860 |
|---|---|
| Sep 2023 | 1,860 |
| Oct 2023 | 1,920 |
| Nov 2023 | 1,920 |
| Dec 2023 | 1,920 |
| Jan 2024 | 1,920 |
| Feb 2024 | 1,920 |
| Mar 2024 | 1,920 |
| Apr 2024 | 1,920 |
| May 2024 | 1,920 |
| Jun 2024 | 1,920 |
| Jul 2024 | 1,920 |
Phibro Animal Health other data
32.88%
-16.47%
of PAHC is owned by hedge funds
91
-38
13.31M
-6.67M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2021 | 0 | 20000 |
| Aug 2021 | 5000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | CORCORAN E THOMAS director | Class A Common Stock | 5,000 | $23.68 | $118,400 | ||
Sale | MILLER LARRY LEE officer: Chief Op.. | Class A Common Stock | 20,000 | N/A | N/A | ||
Option | MILLER LARRY LEE officer: Chief Op.. | Restricted Stock Units | 250,000 | N/A | N/A | ||
Option | MILLER LARRY LEE officer: Chief Op.. | Class A Common Stock | 50,000 | N/A | N/A | ||
Purchase | CORCORAN E THOMAS director | Class A Common Stock | 5,000 | N/A | N/A | ||
Option | BENDHEIM DANIEL M director, officer.. | Option to purchase Common Stock | 2,390 | N/A | N/A | ||
Sale | BENDHEIM DANIEL M director, officer.. | Class A Common Stock | 2,390 | N/A | N/A | ||
Option | BENDHEIM DANIEL M director, officer.. | Class A Common Stock | 2,390 | N/A | N/A | ||
Option | BENDHEIM DANIEL M director, officer.. | Option to purchase Common Stock | 4,890 | N/A | N/A | ||
Sale | BENDHEIM DANIEL M director, officer.. | Class A Common Stock | 4,890 | N/A | N/A |
| Patent |
|---|
Application Filling date: 24 Jan 2022 Issue date: 16 Jun 2022 |
Application Filling date: 17 Dec 2021 Issue date: 7 Apr 2022 |
Application Filling date: 26 Jan 2021 Issue date: 29 Jul 2021 |
Grant Filling date: 14 Mar 2019 Issue date: 11 May 2021 |
Application Filling date: 23 Dec 2020 Issue date: 22 Apr 2021 |
Grant Filling date: 17 Apr 2019 Issue date: 16 Feb 2021 |
Grant Utility: Combination, composition, and method of administering the combination or composition to animals Filling date: 29 Jul 2019 Issue date: 9 Feb 2021 |
Application Filling date: 13 Apr 2020 Issue date: 24 Sep 2020 |
Grant Filling date: 13 Mar 2014 Issue date: 21 Jul 2020 |
Application Filling date: 21 Feb 2020 Issue date: 11 Jun 2020 |
| Quarter | Transcript |
|---|---|
| Q3 2024 10 May 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 8 Feb 2024 | Q2 2024 Earnings Call Transcript |
| Q1 2024 10 Nov 2023 | Q1 2024 Earnings Call Transcript |
| Q4 2023 31 Aug 2023 | Q4 2023 Earnings Call Transcript |
-
What's the price of Phibro Animal Health stock today?
One share of Phibro Animal Health stock can currently be purchased for approximately $31.85.
-
When is Phibro Animal Health's next earnings date?
Unfortunately, Phibro Animal Health's (PAHC) next earnings date is currently unknown.
-
Does Phibro Animal Health pay dividends?
Yes, Phibro Animal Health pays dividends and its trailing 12-month yield is 2.28% with 112% payout ratio.It means that the company is paying a dividend greater than earnings. The last Phibro Animal Health stock dividend of $0.12 was paid on 15 Dec 2021.
-
How much money does Phibro Animal Health make?
Phibro Animal Health has a market capitalization of 874.47M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.07% to 1.02B US dollars. Phibro Animal Health earned 2.42M US dollars in net income (profit) last year or $0.29 on an earnings per share basis.
-
What is Phibro Animal Health's stock symbol?
Phibro Animal Health Corporation is traded on the NASDAQ under the ticker symbol "PAHC".
-
What is Phibro Animal Health's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Phibro Animal Health?
Shares of Phibro Animal Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Phibro Animal Health's key executives?
Phibro Animal Health's management team includes the following people:
- Mr. Jack Clifford Bendheim Chairman, Pres & Chief Executive Officer(age: 78, pay: $3,690,000)
- Mr. Larry L. Miller Chief Operating Officer(age: 61, pay: $1,040,000)
- Mr. Daniel M. Bendheim Executive Vice President of Corporation Strategy & Director(age: 53, pay: $735,630)
- Mr. Thomas G. Dagger Senior Vice President, Gen. Counsel & Corporation Sec.(age: 67, pay: $717,100)
- Mr. Damian Finio Chief Financial Officer(age: 55, pay: $675,910)
-
How many employees does Phibro Animal Health have?
As Jul 2024, Phibro Animal Health employs 1,920 workers.
-
When Phibro Animal Health went public?
Phibro Animal Health Corporation is publicly traded company for more then 11 years since IPO on 11 Apr 2014.
-
What is Phibro Animal Health's official website?
The official website for Phibro Animal Health is pahc.com.
-
Where are Phibro Animal Health's headquarters?
Phibro Animal Health is headquartered at Glenpointe Centre East, Teaneck, NJ.
-
How can i contact Phibro Animal Health?
Phibro Animal Health's mailing address is Glenpointe Centre East, Teaneck, NJ and company can be reached via phone at +20 13 297300.
Phibro Animal Health company profile:
Phibro Animal Health Corporation
pahc.comExchange:
NASDAQ
Full time employees:
1,940
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
Glenpointe Centre East
Teaneck, NJ 07666-6712
Teaneck, NJ 07666-6712
CIK: 0001069899
ISIN: US71742Q1067
CUSIP: 71742Q106
